Evidence map›Paper›PMID 37163141›Full record

ArticleInternational journal of nanomedicine2023

Chemical Synthesis of Innovative Silver Nanohybrids with Synergistically Improved Antimicrobial Properties.

Jianhua Yan, Qifei Wang, Junlin Yang, Paige Rutter, Malcolm Xing, Bingyun Li

Abstract read
In one paragraph

Article in International journal of nanomedicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jianhua YanDepartment of Orthopaedics, School of Medicine, West Virginia University, Morgantown, WV, 26506, USA.
Qifei WangDepartment of Orthopaedics, School of Medicine, West Virginia University, Morgantown, WV, 26506, USA.
Junlin YangSpine Center, Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
Paige RutterDepartment of Orthopaedics, School of Medicine, West Virginia University, Morgantown, WV, 26506, USA.
Malcolm XingDepartment of Mechanical Engineering, University of Manitoba, Winnipeg, R3T2N2, Canada.
Bingyun LiDepartment of Orthopaedics, School of Medicine, West Virginia University, Morgantown, WV, 26506, USA.ORCID 0000-0002-5766-5666

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The wide use of antibiotics has created challenges related to antibiotic-resistant bacteria, which have been increasingly found in recent decades. Antibiotic resistance has led to limited choices of antibiotics. Multiple old antimicrobial agents have high antimicrobial properties toward bacteria, but they unfortunately also possess high toxicity toward humans. For instance, silver (Ag) compounds were frequently used to treat tetanus and rheumatism in the 19th century and to treat colds and gonorrhea in the early 20th century. However, the high toxicity of Ag has limited its clinical use. Purpose: We aimed to reformulate Ag to reduce its toxicity toward human cells like osteoblasts and to optimize its antimicrobial properties. Results: Ag, an old antimicrobial agent, was reformulated by hybriding nanomaterials of different dimensions, and silver nanoparticles (AgNPs) of controllable sizes (95-200 nm) and varying shapes (cube, snowflake, and sphere) were synthesized on carbon nanotubes (CNTs). The obtained AgNP-CNT nanohybrids presented significantly higher killing efficacy against Conclusion: Ag was successfully reformulated and Ag nanohybrids with various AgNP shapes on CNTs were synthesized. The nanohybrids presented significantly enhanced antimicrobial properties and significantly higher osteoblast cell viability compared to AgNPs, showing promise as an innovative antimicrobial nanomaterial for a broad range of biomedical applications.

Indexed as

Anti-Infective AgentsMetal NanoparticlesNanotubes, CarbonAnti-Bacterial AgentsHumansMicrobial Sensitivity TestsSilverStaphylococcus aureusAnti-Bacterial AgentsAnti-Infective AgentsNanotubes, CarbonSilverantibiotic resistanceantimicrobialcytotoxicitynanohybridreformulationsilver nanoparticle

Identifiers

PMID37163141
PMCPMC10164387

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.